Child Development, Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:175-179. doi: 10.1016/j.pnpbp.2018.05.022. Epub 2018 Jun 1.
We aimed to examine the effects of infertility treatments on the risk of Autism Spectrum Disorder (ASD). Data were from a representative national registry on 110,093 male live births in Israel (born: 1999-2008; and ASD: 975, 0.9%). Infertility treatments included In Vitro Fertilization (IVF), and five hormone treatments. Relative risk (RR) was estimated with multivariable logistic models. Results showed that IVF treatment compared with spontaneous conception was not statistically significantly associated with the risk of ASD. Only progesterone hormone treatment was associated with a statistically significant (p < .05) increased risk of ASD (RR = 1.51, 95% CI 1.22, 1.86) compared to the group with no progesterone treatment. In conclusion, progesterone exposure during the critical period of fetal life elevated the risk of ASD, possibly reflecting epigenetic modification.
我们旨在研究不孕治疗对自闭症谱系障碍(ASD)风险的影响。数据来自以色列一项针对 110093 名男性活产儿的代表性全国登记处(出生于 1999 年至 2008 年;ASD:975,0.9%)。不孕治疗包括体外受精(IVF)和五种激素治疗。相对风险(RR)采用多变量逻辑模型估计。结果表明,与自然受孕相比,IVF 治疗与 ASD 风险无统计学显著相关性。只有孕激素激素治疗与 ASD 风险显著增加相关(RR=1.51,95%CI 1.22,1.86),与未接受孕激素治疗的组相比。总之,胎儿生命关键期孕激素暴露增加了 ASD 的风险,可能反映了表观遗传修饰。